1 Growth Stock Down 19% to Buy Right Now [Yahoo! Finance]
DexCom, Inc. (DXCM)
Last dexcom, inc. earnings: 4/28 04:03 pm
Check Earnings Report
US:NASDAQ Investor Relations:
dexcom.com/investors
Company Research
Source: Yahoo! Finance
10 stocks we like better than DexCom › Last year was not a good one for Dexcom (NASDAQ: DXCM) . The medical device specialist lagged the market, and even with a bit of a rebound toward the second half of 2025, shares are down 19% over the trailing-12-month period. However, there are still great reasons to consider investing in Dexcom. Let's see why the healthcare company could be a great buy. Dexcom is a medical device specialist that manufactures and markets continuous glucose monitoring (CGM) devices, which help diabetes patients track their blood sugar levels throughout the day. Last year, the company faced the ire of regulators and complaints from some of its customers because some of its CGM receivers were defective. The receivers' speakers malfunctioned and failed to audibly alert patients of critically low (or high) blood sugar. Dexcom faced a Class 1 recall for 602,445 of its G7 receivers. However, this doesn't mean that many receivers were actually defective -- recal
Show less
Read more
Impact Snapshot
Event Time:
DXCM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DXCM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DXCM alerts
High impacting DexCom, Inc. news events
Weekly update
A roundup of the hottest topics
DXCM
News
- HALPER SADEH LLC ENCOURAGES DEXCOM, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTSPR Newswire
- Barclays Downgrades Dexcom (DXCM) to Underweight Citing Intensifying Competition in Core Segments [Yahoo! Finance]Yahoo! Finance
- Dexcom Schedules Fourth Quarter and Fiscal Year 2025 Earnings Release and Conference Call for February 12, 2026 at 4:30 p.m. Eastern Time.Business Wire
- INVESTOR NOTICE: Kaskela Law Firm Announces Stockholder Investigation of DexCom, Inc. (NASDAQ: DXCM) and Encourages Long-Term Investors to Contact the FirmPR Newswire
- Assessing DexCom (DXCM) Valuation After Recent Share Price Momentum And Conflicting Fair Value Signals [Yahoo! Finance]Yahoo! Finance
DXCM
Earnings
- 10/30/25 - Beat
DXCM
Sec Filings
- 1/12/26 - Form 8-K
- 12/22/25 - Form 8-K
- 11/17/25 - Form 4
- DXCM's page on the SEC website